AC Immune
ACIU
36 hedge funds and large institutions have $57.2M invested in AC Immune in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 10 closing their positions.
115% more call options, than puts
Call options by funds: $942K | Put options by funds: $439K
1.04% less ownership
Funds ownership: 20.71% → 19.67% (-1%)
18% less funds holding
Funds holding: 44 → 36 (-8)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
23% less capital invested
Capital invested by funds: $74.5M → $57.2M (-$17.3M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.58M |
| 2 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$438K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$335K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$106K |
| 5 |
HF
HRT Financial
New York
|
+$45.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$1.72M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.15M |
| 3 |
Morgan Stanley
New York
|
-$1.03M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$362K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$319K |
ACIU Hedge Fund Activity: Q1 2022 in Review
36 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2022, worth a combined $57.2M — down 23% from $74.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ACIU and 3 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 10 added.
The largest buyer was BVF Inc, adding an estimated $1.58M. The largest seller was Lombard Odier Asset Management (Switzerland), exiting entirely with an estimated $1.72M sold.
- 36 institutional investors held AC Immune (ACIU) as of Q1 2022, down from 44 in Q4 2021.
- Funds reported $57.2M of AC Immune stock for Q1 2022, down 23% quarter-over-quarter.
- 3 funds opened new AC Immune positions in Q1 2022 and 10 closed out, a net change of -7 holders.
- The largest AC Immune buyer in Q1 2022 was BVF Inc, an estimated $1.58M added.
- The largest AC Immune seller in Q1 2022 was Lombard Odier Asset Management (Switzerland), an estimated $1.72M sold.
Based on aggregated 13F filings for Q1 2022.